Attenuation of Nerve Agent Induced Neurodegenerative and Neuroinflammatory Changes in Rats with New Combination Treatment of Galantamine, Atropine and Midazolam
Molecular Neurobiology · 2025
DOI: 10.1007/s12035-024-04294-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Neurobiology, 2025. Verfasst von Naveen Singh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Verification Division, Defence Research and Development Establishment (DRDE), Jhansi Road, Gwalior, M.P, India. Hauptthemen laut MEDLINE: Atropine, Nerve Agents, Midazolam, Galantamine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Acute nerve agent exposure can kill a person within minutes or produce multiple neurotoxic effects and subsequent brain damage with potential long-term adverse outcomes. Recent abuse of nerve-agents on Syrian civilians, during Japan terrorist attacks, and personal assassinations in the UK, and Malaysia indicate their potential threat to world population. Existing nerve agent antidotes offer only incomplete protection especially, if the treatment is delayed. To develop the effective drugs, it is advantageous to elucidate the underlying mechanisms of nerve agent-induced multiple neurological impairments. This study aimed to investigate the molecular basis of neuroinflammation during nerve agent toxicity with focus on inflammasome-associated proteins and neurodegeneration. In rats, NOD-like receptor family pyrin domain containing 3 (NLRP3), and glial fibrillary acidic protein (GFAP) immunoreactivity levels were considerably increased in the hippocampus, piriform cortex, and amygdala areas after single subcutaneous soman exposure (90 µg/kg-1). Western analysis indicated a notable increase in the neuroinflammatory indicator proteins, high mobility group box 1 (HMGB1) and inducible nitric oxide synthase (iNOS) levels. The presence of fluorojade-C-stained degenerating neurons in distinct rat brain areas is indicating the neurodegeneration during nerve agent toxicity. Pre-treatment with galantamine (3 mg/kg, - 30 min) followed by post-treatment of atropine (10 mg/kg, i.m.) and midazolam (5 mg/kg, i.m.), has completely protected animals from death induced by supra-lethal dose of soman (2XLD50) and reduced the neuroinflammatory and neurodegenerative changes. Results highlight that this new prophylactic and therapeutic drug combination might be an effective treatment option for soldiers deployed in conflict areas and first responders dealing with accidental/deliberate release of nerve agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Verification Division, Defence Research and Development Establishment (DRDE), Jhansi Road, Gwalior, M.P, India.
- Biomedical Verification Division, Defence Research and Development Establishment (DRDE), Jhansi Road, Gwalior, M.P, India. ramugolime@gmail.com.
- Department of Epidemiology and Public Health, Central University of Tamil Nadu, Thiruvarur, India. ramugolime@gmail.com.
- Animal Facility Division, DRDE, Jhansi Road, Gwalior, M.P, India.
- Process Technology Development Division, DRDE, Jhansi Road, Gwalior, M.P, India.
Zitieren
APA
Singh, N., Golime, R., Kumar, A., & Roy, T. (2025). Attenuation of Nerve Agent Induced Neurodegenerative and Neuroinflammatory Changes in Rats with New Combination Treatment of Galantamine, Atropine and Midazolam. Molecular Neurobiology. https://doi.org/10.1007/s12035-024-04294-2
Vancouver
Singh N, Golime R, Kumar A, Roy T. Attenuation of Nerve Agent Induced Neurodegenerative and Neuroinflammatory Changes in Rats with New Combination Treatment of Galantamine, Atropine and Midazolam. Molecular Neurobiology. 2025. doi:10.1007/s12035-024-04294-2
BibTeX
@article{Singh2025,
author = {Singh, Naveen and Golime, RamaRao and Kumar, Abdhesh and Roy, Tuhin},
title = {Attenuation of Nerve Agent Induced Neurodegenerative and Neuroinflammatory Changes in Rats with New Combination Treatment of Galantamine, Atropine and Midazolam},
journal = {Molecular Neurobiology},
year = {2025},
doi = {10.1007/s12035-024-04294-2}
}
EUVIMED